Clinical Trials in San Francisco

Showing 10381-10400 of 12,991 trials

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

NCT01709474

The primary objective of this study is to evaluate the effects of 18 weeks of high-dose vitamin D3 supplementation compared with standard-dose vitamin D3 supplementation on immune function, glucose homeostasis, and bone metabolism in children with systemic lupus erythematosus (SLE) and serum 25-hydroxyvitamin D \[25(OH)D\] levels ≤20 ng/mL.

Systemic Lupus Erythematosus

National Institute of Allergy and Infectious Diseases (NIAID)7 participantsStarted Jun 2013

Los Angeles, California, United States • Palo Alto, California, United States • San Francisco, California, United States +10 more locations

COMPLETEDPhase 28.4 miles

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

NCT01109524

The purpose of the study is to determine if U.S. manufactured Cetuximab can be safely used for the treatment of Non-Small Cell Lung Cancer in combination with Cisplatin and Vinorelbine.

Lung NeoplasmsCarcinomaCancer of the Lung+1 more

Eli Lilly and Company72 participantsStarted Jul 2010

Casa Grande, Arizona, United States • Beverly Hills, California, United States • Los Angeles, California, United States +19 more locations

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Find Trials by Condition in San Francisco

A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Computer-Based Physical Activity Advice for Ethnic Minority Aging Adults

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection

Prehospital Resuscitation On Helicopter Study

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis